# The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients

> **NCT02496780** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 65 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** novolog insulin
- **DRUG:** levemir insulin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02496780
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496780, "The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02496780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*